Stock RNXT RENOVORX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RenovoRx, Inc.

Equities

RNXT

US75989R1077

Market Closed - Nasdaq
Other stock markets
 21:30:00 25/06/2024 BST 		5-day change 1st Jan Change
1.13 USD -1.31% Intraday chart for RenovoRx, Inc. -17.52% -50.66%
06-10 RenovoRx, Inc. Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships CI
05-21 RenovoRx, Inc. Announces Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
RENOVORX, INC. Stock RenovoRx, Inc.
 27.07M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 116B
ARGENX SE Stock argenx SE
 27.03B -
BIONTECH SE Stock BioNTech SE
 20.36B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 15.91B -
  1. Stock Market
  2. Equities
  3. RNXT Stock
  4. Charts RenovoRx, Inc.
  5. Sector Chart